Recent research has revealed important new insights into the role of genetic diversity in drug resistance markers. In a study published in the journal Nature Communications, researchers from the University of California, Berkeley, utilized a novel genomic technique to investigate the genetic basis of drug resistance in a widely used cancer drug, doxorubicin.

The team found that the genetic diversity of drug resistance markers plays a significant role in the emergence of drug resistance in cancer cells. In particular, they found that the presence of genetic diversity within drug resistance markers can lead to an increase in the resistance of cancer cells to the drug. Additionally, the researchers observed that genetic diversity can also lead to a decrease in the drug’s effectiveness. This suggests that increased genetic diversity may be a key factor in the emergence of drug resistance in cancer cells.

Read Full Article Here

source: Phys.org